NCT05189392 (PICO-PTA) is a NA clinical trial of PICO in Evaluate Postsurgical Hematoma, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

Who is sponsoring NCT05189392?

NCT05189392 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What drugs are being tested in NCT05189392?

Interventions in NCT05189392: PICO.

What condition does NCT05189392 study?

NCT05189392 studies Evaluate Postsurgical Hematoma.

Is NCT05189392 still recruiting?

NCT05189392 is currently status unknown. Last updated 12 January 2022.

Last reviewed 2022-01-12 · How we verify

NCT05189392: PICO-PTA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of PICO Compared to Opsite Post-Op Visible on Surgical Wound in Patients at High Risk of Local Complications, Undergoing Hip Arthroplasty

Status unknown NA Last updated 12 January 2022

What this trial tests

NA trial testing PICO in Evaluate Postsurgical Hematoma in 42 participants. Status unknown.

Timeline

10 January 2022

Primary endpoint
10 December 2024

10 January 2025

Quick facts

Lead sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	42
Start date	10 January 2022
Primary completion	10 December 2024
Estimated completion	10 January 2025
Sites	1 location across Italy

Drugs / interventions tested

PICO

Conditions studied

Evaluate Postsurgical Hematoma — all drugs for Evaluate Postsurgical Hematoma →

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

Adults 55 to 85, any sex, with Evaluate Postsurgical Hematoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the effect of the PICO medical device, compared to the Opsite Post-Op Visible medical device, in reducing the formation of postsurgical hematoma in the surgical wound of patients at high risk of local complications, undergoing hip arthroplasty

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PICO

Trials testing the same drug.

NCT03452852 — Prospective, RCT of Split Thickness Skin Grafts on Lower Leg After Compression Therapy With Compression Bandage vs. NPWT · NA · unknown

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
NCT07304323 — Prepare II - Predictive Model Training and External Validation · recruiting
NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05189392 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Last refreshed: 12 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05189392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing